Clinical trial
Long-term Outcome of TNF Alpha Therapy in IBD
NCT04575701 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Outcome of TNF Alpha Therapy in IBD
- Lead sponsor
- Medical University of Graz
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2019
- Completion date
- July 1, 2020
- Enrollment
- 538 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ibd